Metropolis Healthcare Ltd

Metropolis Healt Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Metropolis Healthcare Ltd

₹ 1,700 0.11%
11 Jun 1:37 p.m.
metropolisindia.com BSE: 542650 NSE: METROPOLIS
About

Metropolis Healthcare Limited is one of the leading Indian diagnostics companies. The Company owns a chain of diagnostic centres across India, South Asia, Africa and the Middle East.

Key Points

Leading Diagnostics company[1] Metropolis Healthcare Ltd is the second largest Diagnostic company in India and the largest player in Western and Southern India.

Website BSE NSE
  • Market Cap ₹ 8,804 Cr.
  • Current Price ₹ 1,700
  • High / Low ₹ 2,318 / 1,315
  • Stock P/E 70.5
  • Book Value ₹ 240
  • Dividend Yield 0.24 %
  • ROCE 13.6 %
  • ROE 11.0 %
  • Face Value ₹ 2.00
Edit ratios

Pros

Cons

  • Stock is trading at 7.09 times its book value
  • Promoter holding has decreased over last quarter: -0.51%
  • Company has a low return on equity of 12.6% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Healthcare Service Provider

Part of BSE 500 BSE Healthcare Nifty 500 BSE SmallCap BSE Allcap

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
285 257 280 265 264 256 285 269 292 286 322 297 312
216 196 205 199 197 198 218 211 218 218 240 232 259
Operating Profit 69 61 75 66 68 58 67 59 74 68 82 65 53
OPM % 24% 24% 27% 25% 26% 23% 24% 22% 25% 24% 26% 22% 17%
6 2 3 7 9 3 2 5 2 3 4 3 8
Interest 6 8 7 6 6 6 6 5 6 5 5 4 4
Depreciation 17 20 20 22 22 20 21 24 25 25 26 27 27
Profit before tax 52 36 51 44 48 35 42 35 45 42 55 37 29
Tax % 28% 20% 25% 26% 17% 26% 26% 23% 29% 25% 23% 26% 17%
37 28 38 33 40 26 31 27 32 31 42 27 24
EPS in Rs 7.27 5.55 7.39 6.41 7.80 5.10 6.11 5.21 6.20 6.11 8.25 5.34 4.60
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
223 254 349 405 485 581 665 961 1,157 1,066 1,103 1,217
159 183 263 289 348 434 489 677 833 792 840 948
Operating Profit 64 71 86 115 137 148 176 285 324 274 263 268
OPM % 29% 28% 25% 29% 28% 25% 26% 30% 28% 26% 24% 22%
15 6 39 30 15 20 5 12 32 21 12 17
Interest 2 2 1 2 3 3 10 11 25 31 27 18
Depreciation 8 10 12 12 14 15 31 44 60 85 91 105
Profit before tax 69 65 112 131 135 149 140 242 272 179 157 162
Tax % 33% 33% 32% 33% 29% 32% 20% 25% 27% 22% 26% 23%
46 43 76 88 96 101 112 183 200 139 116 125
EPS in Rs 47.12 43.64 79.59 92.21 100.34 20.22 22.13 35.73 38.99 27.13 22.62 24.09
Dividend Payout % 3% 0% 101% 57% 0% 66% 36% 22% 21% 29% 18% 0%
Compounded Sales Growth
10 Years: 17%
5 Years: 13%
3 Years: 2%
TTM: 10%
Compounded Profit Growth
10 Years: 12%
5 Years: -1%
3 Years: -13%
TTM: 8%
Stock Price CAGR
10 Years: %
5 Years: 3%
3 Years: 2%
1 Year: -15%
Return on Equity
10 Years: 20%
5 Years: 17%
3 Years: 13%
Last Year: 11%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 10 10 10 10 10 10 10 10 10 10 10 10
Reserves 254 296 233 258 354 405 502 655 829 926 1,021 1,234
16 10 4 0 0 17 54 111 377 268 195 178
33 35 95 170 76 95 122 163 242 230 247 262
Total Liabilities 313 351 341 438 440 528 688 939 1,459 1,434 1,473 1,685
83 84 92 152 157 163 216 307 1,005 1,066 1,120 1,129
CWIP 0 0 0 0 0 6 3 0 6 20 0 0
Investments 148 175 120 143 98 135 130 12 50 50 90 321
82 92 129 143 185 224 340 620 398 299 263 235
Total Assets 313 351 341 438 440 528 688 939 1,459 1,434 1,473 1,685

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
52 43 75 77 74 56 156 236 244 238 269 275
-39 -36 101 -67 19 -4 -51 59 -736 47 -82 -196
-10 -10 -165 -17 -82 -64 -46 -31 172 -288 -183 -84
Net Cash Flow 3 -3 11 -6 12 -12 59 264 -320 -3 4 -6

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 50 60 50 56 62 74 68 50 44 43 43 34
Inventory Days 49 50 42 35 49 52 38 57 66 64 56 47
Days Payable 64 71 84 93 87 95 155 143 131 133 155 160
Cash Conversion Cycle 34 38 7 -1 24 31 -48 -36 -22 -26 -55 -79
Working Capital Days 60 48 12 -47 43 57 29 16 23 24 10 19
ROCE % 22% 37% 50% 43% 38% 35% 38% 28% 17% 15% 14%

Shareholding Pattern

Numbers in percentages

2 Recently
Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
49.79% 49.76% 49.76% 49.75% 49.75% 49.75% 49.74% 49.67% 49.62% 49.43% 49.40% 48.89%
23.20% 25.57% 23.86% 25.67% 25.66% 24.29% 21.66% 18.90% 18.25% 18.56% 16.73% 15.29%
14.50% 12.38% 13.30% 13.64% 14.89% 16.86% 20.73% 24.86% 27.42% 28.02% 30.00% 30.30%
12.52% 12.30% 13.09% 10.94% 9.69% 9.10% 7.87% 6.57% 4.69% 3.98% 3.86% 5.51%
No. of Shareholders 86,40490,09091,45284,26989,69286,24979,87868,28358,10851,85248,57249,293

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls